Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0344307 (
analgesia
)
28,200
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of i.p. administration of kappa-opioid receptor agonists, bremazocine, tifluadom and U-50,488H on morphine (8 mg/kg i.p.)-induced
analgesia
in morphine-naive and morphine tolerant male Sprague-Dawley rats was determined using the tail-flick test. The tolerance to morphine in the rats was induced by s.c., implantation of six morphine pellets during a 7-day period. Implantation of morphine pellets resulted in the development of tolerance as evidenced by the decrease in the analgesic response to morphine when compared to placebo pellets implanted rats.
Bremazocine
(0.3, 1.0 and 3.0 mg/kg) and U-50,488H (16 mg/kg) antagonized morphine-induced
analgesia
in morphine-naive rats while tifluadom (8 and 16 mg/kg) potentiated the effect. In morphine-tolerant rats, bremazocine (3 mg/kg) and U-50,488H (16 mg/kg) potentiated morphine-induced
analgesia
. Tifluadom at any of the doses had no effect on morphine-induced
analgesia
in morphine-tolerant rats. These results provide evidence that different kappa-opioid agonists modify morphine-induced
analgesia
differentially in morphine-naive and morphine-tolerant rats.
...
PMID:Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats. 285 74
In three experiments we examined the analgesic potency of kappa opioid receptor agonists in 2- and 16-day-old rats. Ethylketocyclazocine (1-50 mg/kg) produced similar dose- and time-dependent increases in the latency to retract a hind paw from a noxious thermal stimulus in rats of both ages.
Bremazocine
(0.001-10 mg/kg), a kappa agonist with reported antagonist activity at mu receptors, was also effective in producing
analgesia
in 2-day-old rats. The dose-effect relationship for bremazocine was nonmonotonic.
Bremazocine
analgesia
(0.1 mg/kg) was reversed by both naltrexone and MR2266, a putative kappa opioid antagonist. These results are discussed in terms of the functional integrity of a kappa analgesic system in the developing rat.
...
PMID:Ethylketocyclazocine and bremazocine analgesia in neonatal rats. 306 43